INOZYME PHARMA, INC. Total Long-Term Debt
INOZYME PHARMA, INC. had Total Long-Term Debt of $20.59 million as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:LongTermDebt · last filed 2025-05-14
- 2025-03-31: Long-term Debt $20.59M.
- 2024-12-31: Long-term Debt $31.46M.
- 2024-09-30: Long-term Debt $42.06M.
- 2024-06-30: Long-term Debt $45.33M.
| Period end | Long-term Debt |
|---|---|
| 2025-03-31 | $20.59M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $31.46M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $42.06M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $45.33M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $45.03M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $44.77M 10-K · filed 2025-03-10 |
| 2023-09-30 | $32.06M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $31.88M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $24.22M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $4.14M 10-K · filed 2024-03-12 |
| 2022-09-30 | $4.07M 10-Q · filed 2022-11-10 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-22 |